| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net sales | $5.04B+0.9% | $4.99B-1.4% | $5.06B-2.7% | $5.20B-10.3% | $5.80B |
| Cost of sales | $1.11B+0.9% | $1.10B-7.3% | $1.19B+1.5% | $1.17B-5.3% | $1.24B |
| Gross profit | $3.92B+0.9% | $3.89B+0.4% | $3.87B-4.0% | $4.03B-11.7% | $4.56B |
| Selling expenses | $1.78B-0.0% | $1.78B-2.3% | $1.82B | — | — |
| General and administrative expenses | $1.66B-3.6% | $1.73B+1.4% | $1.70B | — | — |
| Other operating income | -$4.8M+12.7% | -$5.5M+46.1% | -$10.2M+31.5% | -$14.9M+9.1% | -$16.4M |
| Operating income | $481.0M+24.6% | $385.9M+8.3% | $356.4M-34.6% | $545.2M-25.7% | $734.1M |
| Interest expense | $214.4M-1.8% | $218.3M+31.6% | $165.9M+19.1% | $139.3M-9.0% | $153.1M |
| Interest income | $8.5M-30.9% | $12.3M+7.0% | $11.5M+88.5% | $6.1M+38.6% | $4.4M |
| Other expense (income), net | $0-100.0% | $10.5M+1150.0% | -$1.0M+92.2% | -$12.8M-152.0% | $24.6M |
| Income before income taxes | $275.1M+62.4% | $169.4M-16.6% | $203.0M-52.2% | $424.8M-24.3% | $560.8M |
| Income taxes | $47.3M+155.7% | -$84.9M-239.6% | $60.8M-41.3% | $103.5M-8.9% | $113.6M |
| Net Income | $227.8M-10.4% | $254.3M+78.8% | $142.2M | — | — |
| Net loss attributable to noncontrolling interest | -$500K | $0 | $0 | — | — |
| Net income attributable to Herbalife | $228.3M-10.2% | $254.3M+78.8% | $142.2M-55.7% | $321.3M-28.2% | $447.2M |
| Basic | $102.8M+2.2% | $100.6M+1.6% | $99.0M+0.5% | $98.5M-7.0% | $105.9M |
| Diluted | $103.6M+2.0% | $101.6M+1.4% | $100.2M+0.7% | $99.5M-8.1% | $108.3M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.